
Phoenix A Ho MD
Pediatric Hematology & Oncology at Seattle Children's Hospital
Join to View Full Profile
2324 Eastlake Ave E Ste 500Seattle, WA 98102
Phone+1 206-543-8606
Fax+1 206-987-3946
Dr. Ho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- U Washington Affil Hosps2009
- Yale-New Haven Medical CenterResidency, Pediatrics, 2003 - 2006
- Yale-New Haven Medical CenterInternship, Pediatrics, 2003 - 2004
- Northeast Ohio Medical UniversityClass of 2003
Certifications & Licensure
- WA State Medical License 2006 - 2027
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia Start of enrollment: 2013 Feb 01
- Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
- A Safety Study of SGN-CD33A in AML Patients Start of enrollment: 2013 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsA phase I study of panobinostat in children with relapsed and refractory hematologic malignanciesJohn Goldberg, Maria Luisa Sulis, Julia Glade Bender, Sima Jeha, Rebecca Gardner
Pediatric Hematology and Oncology. 2020-04-27 - 24 citationsA phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemiaC. Michel Zwaan, Stefan Söderhäll, Benoit Brethon, Matteo Luciani, Carmelo Rizzari
British Journal of Haematology. 2019-05-01 - 49 citationsA phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AMLAmir T. Fathi, Harry P. Erba, Jeffrey E. Lancet, Eytan M. Stein, Farhad Ravandi
Blood. 2018-09-13
Journal Articles
- A Phase 1 Trial of Vadastuximab Talirine Combined with Hypomethylating Agents in Patients with CD33 Positive AMLEytan M Stein, Anand Jillella, Anthony S Stein, Amir T Fathi, Roland B Walter, Jeffrey E Lancet, Tibor J Kovacsovics, Anjali S Advani, Phoenix A Ho, Dale Bixby, Blood
Grant Support
- Exploiting WT1 Alterations in Pediatric AMLSt. Baldrick's Foundation2012–2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: